Sentiment on the MLP sector has soured, to the point where major MLPs could convert to corporations. Here's what investors need to know. Read More

The Federal Reserve’s acquisition of toxic corporate debt is creating “undead companies” that could devour the economy and kill the rally. Read More

It’s too late to get in on Tesla, but it’s not too late to join the EV gold rush if you buy this overlooked exchange-traded fund. Read More

Second-quarter earnings season soon kicks into gear and it’s likely to be dreadful on many levels. Here’s what to expect and how to cope. Read More

We spoke with an expert on our staff about how investors should position their portfolios amid pandemic-caused uncertainty. Read More

Here’s a roundup of the latest legal and regulatory developments affecting the marijuana industry and its investors. Read More

The pandemic-crushed economy cries out for another stimulus bill, but don’t expect Congress to pass anything between now and November. Read More

The trade we recommended for Novavax two months ago racked up a 500% gain. Now, we suggest a different strategy to profit from its extreme volatility. Read More

We’re witnessing unsustainable asset price inflation, fueled by massive monetary stimulus. Here’s how to trade, before the stock market crashes. Read More

Buying micro-cap stocks can offer huge returns akin to call options, but without the limitations of options. Here's how to find the right small fry. Read More